Tet2 and Tet3 cooperate with B-lineage transcription factors to regulate DNA modification and chromatin accessibility

eLife

Volumn 5, Issue NOVEMBER2016, 2016, Pages

  Lio, Chan Wang ^a   Zhang, Jiayuan ^b   González Avalos, Edahí ^a   Hogan, Patrick G ^a   Chang, Xing ^a,b,c   Rao, Anjana ^a,c,d,e  

^a La Jolla Institute   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c Sanford Consortium for Regenerative Medicine   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLCYTOSINE; ABELSON KINASE; B LYMPHOCYTE ANTIBODY; INTERFERON REGULATORY FACTOR 4; PEPTIDES AND PROTEINS; TEN ELEVEN TRANSLOCATION PROTEIN 2; TEN ELEVEN TRANSLOCATION PROTEIN 3; TRANSCRIPTION FACTOR E2A; UNCLASSIFIED DRUG; CHROMATIN; DNA; DNA BINDING PROTEIN; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR-4; ONCOPROTEIN; TET2 PROTEIN, MOUSE; TET3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CELL MATURATION; CHROMATIN; CONTROLLED STUDY; DNA MODIFICATION; DNA TRANSCRIPTION; ENHANCER REGION; ENZYME ACTIVITY; FLOW CYTOMETRY; HISTONE MODIFICATION; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRE B LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION; ANIMAL; B LYMPHOCYTE; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETIC TRANSCRIPTION; METABOLISM; PHYSIOLOGY;

5-METHYLCYTOSINE; ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CHROMATIN; DNA; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; INTERFERON REGULATORY FACTORS; MICE; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION, GENETIC;

EID: 85005995773     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.18290     Document Type: Article

References (82)

1. Alt FW, Zhang Y, Meng FL, Guo C, Schwer B. 2013. Mechanisms of programmed DNA lesions and genomic instability in the immune system. Cell 152: 417-429. doi: 10.1016/j.cell.2013.01.007, PMID: 23374339
2. An J, González-Avalos E, Chawla A, Jeong M, López-Moyado IF, Li W, Goodell MA, Chavez L, Ko M, Rao A. 2015. Acute loss of TET function results in aggressive myeloid cancer in mice. Nature Communications 6: 10071. doi: 10.1038/ncomms10071, PMID: 26607761
3. Balasubramani A, Rao A. 2013. O-GlcNAcylation and 5-methylcytosine oxidation: an unexpected association between OGT and TETs. Molecular Cell 49: 618-619. doi: 10.1016/j.molcel.2013.02.006, PMID: 23438858
4. Benner C, Isoda T, Murre C. 2015. New roles for DNA cytosine modification, eRNA, anchors, and superanchors in developing B cell progenitors. PNAS 112: 12776-12781. doi: 10.1073/pnas.1512995112
5. Bestor TH, Edwards JR, Boulard M. 2015. Notes on the role of dynamic DNA methylation in mammalian development. PNAS 112: 6796-6799. doi: 10.1073/pnas.1415301111
6. Bevington S, Boyes J. 2013. Transcription-coupled eviction of histones H2A/H2B governs V(D)J recombination. The EMBO Journal 32: 1381-1392. doi: 10.1038/emboj.2013.42, PMID: 23463099
7. Boller S, Ramamoorthy S, Akbas D, Nechanitzky R, Burger L, Murr R, Schübeler D, Grosschedl R. 2016. Pioneering activity of the C-terminal domain of EBF1 shapes the chromatin landscape for B cell programming. Immunity 44: 527-541. doi: 10.1016/j.immuni.2016.02.021, PMID: 26982363
8. Bossen C, Mansson R, Murre C. 2012. Chromatin topology and the regulation of antigen receptor assembly. Annual Review of Immunology 30: 337-356. doi: 10.1146/annurev-immunol-020711-075003, PMID: 22224771
9. Bossen C, Murre CS, Chang AN, Mansson R, Rodewald HR, Murre C. 2015. The chromatin remodeler Brg1 activates enhancer repertoires to establish B cell identity and modulate cell growth. Nature Immunology 16: 775-784. doi: 10.1038/ni.3170, PMID: 25985234
10. Buenrostro JD, Giresi PG, Zaba LC, Chang HY, Greenleaf WJ. 2013. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nature Methods 10: 1213-1218. doi: 10.1038/nmeth.2688, PMID: 24097267
11. Chen YY, Wang LC, Huang MS, Rosenberg N. 1994. An active v-abl protein tyrosine kinase blocks immunoglobulin light-chain gene rearrangement. Genes & Development 8: 688-697. doi: 10.1101/gad.8.6.688
12. Cherry SR, Beard C, Jaenisch R, Baltimore D. 2000. V(D)J recombination is not activated by demethylation of the kappa locus. PNAS 97: 8467-8472. doi: 10.1073/pnas.150218497
13. Cimmino L, Dawlaty MM, Ndiaye-Lobry D, Yap YS, Bakogianni S, Yu Y, Bhattacharyya S, Shaknovich R, Geng H, Lobry C, Mullenders J, King B, Trimarchi T, Aranda-Orgilles B, Liu C, Shen S, Verma AK, Jaenisch R, Aifantis I. 2015. TET1 is a tumor suppressor of hematopoietic malignancy. Nature Immunology 16: 653-662. doi: 10.1038/ni.3148, PMID: 25867473
14. Clark MR, Mandal M, Ochiai K, Singh H. 2014. Orchestrating B cell lymphopoiesis through interplay of IL-7 receptor and pre-B cell receptor signalling. Nature Reviews. Immunology 14: 69-80. doi: 10.1038/nri3570, PMID: 24378843
15. Cobaleda C, Schebesta A, Delogu A, Busslinger M. 2007. Pax5: the guardian of B cell identity and function. Nature Immunology 8: 463-470. doi: 10.1038/ni1454, PMID: 17440452
16. Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, Steine EJ, Hanna J, Lodato MA, Frampton GM, Sharp PA, Boyer LA, Young RA, Jaenisch R. 2010. Histone H3K27ac separates active from poised enhancers and predicts developmental state. PNAS 107: 21931-21936. doi: 10.1073/pnas.1016071107
17. Curry JD, Li L, Schlissel MS. 2005. Quantification of Jkappa signal end breaks in developing B cells by blunt-end linker ligation and qPCR. Journal of Immunological Methods 296: 19-30. doi: 10.1016/j.jim.2004.10.003, PMID: 15680147
18. de la Rica L, Rodríguez-Ubreva J, Garcıá M, Islam AB, Urquiza JM, Hernando H, Christensen J, Helin K, Gómez-Vaquero C, Ballestar E. 2013. PU.1 target genes undergo Tet2-coupled demethylation and DNMT3b-mediated methylation in monocyte-to-osteoclast differentiation. Genome Biology 14: R99. doi: 10.1186/gb-2013-14-9-r99, PMID: 24028770
19. ENCODE Project Consortium. 2012. An integrated encyclopedia of DNA elements in the human genome. Nature 489: 57-74. doi: 10.1038/nature11247, PMID: 22955616
20. Flavahan WA, Drier Y, Liau BB, Gillespie SM, Venteicher AS, Stemmer-Rachamimov AO, SuvàML, Bernstein BE. 2016. Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature 529: 110-114. doi: 10.1038/nature16490, PMID: 26700815
21. Ghisletti S, Barozzi I, Mietton F, Polletti S, De Santa F, Venturini E, Gregory L, Lonie L, Chew A, Wei CL, Ragoussis J, Natoli G. 2010. Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity 32: 317-328. doi: 10.1016/j.immuni.2010.02.008, PMID: 20206554
22. Gu TP, Guo F, Yang H, Wu HP, Xu GF, Liu W, Xie ZG, Shi L, He X, Jin SG, Iqbal K, Shi YG, Deng Z, SzabóPE, Pfeifer GP, Li J, Xu GL, Jin Seung-gi. 2011. The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes. Nature 477: 606-610. doi: 10.1038/nature10443, PMID: 21892189
23. Guilhamon P, Eskandarpour M, Halai D, Wilson GA, Feber A, Teschendorff AE, Gomez V, Hergovich A, Tirabosco R, Fernanda Amary M, Baumhoer D, Jundt G, Ross MT, Flanagan AM, Beck S. 2013. Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2. Nature Communications 4: 2166. doi: 10.1038/ncomms3166, PMID: 23863747
24. Guo W, Fiziev P, Yan W, Cokus S, Sun X, Zhang MQ, Chen PY, Pellegrini M. 2013. BS-Seeker2: a versatile aligning pipeline for bisulfite sequencing data. BMC Genomics 14: 774. doi: 10.1186/1471-2164-14-774, PMID: 24206606
25. Hagman J, Lukin K. 2006. Transcription factors drive B cell development. Current Opinion in Immunology 18: 127-134. doi: 10.1016/j.coi.2006.01.007, PMID: 16464566
26. He YF, Li BZ, Li Z, Liu P, Wang Y, Tang Q, Ding J, Jia Y, Chen Z, Li L, Sun Y, Li X, Dai Q, Song CX, Zhang K, He C, Xu GL. 2011. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 333: 1303-1307. doi: 10.1126/science.1210944, PMID: 21817016
27. Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H, Glass CK. 2010. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Molecular Cell 38: 576-589. doi: 10.1016/j.molcel.2010.05.004, PMID: 20513432
28. Hobeika E, Thiemann S, Storch B, Jumaa H, Nielsen PJ, Pelanda R, Reth M. 2006. Testing gene function early in the B cell lineage in mb1-cre mice. PNAS 103: 13789-13794. doi: 10.1073/pnas.0605944103
29. Hodges E, Molaro A, Dos Santos CO, Thekkat P, Song Q, Uren PJ, Park J, Butler J, Rafii S, McCombie WR, Smith AD, Hannon GJ. 2011. Directional DNA methylation changes and complex intermediate states accompany lineage specificity in the adult hematopoietic compartment. Molecular Cell 44: 17-28. doi: 10.1016/j.molcel.2011.08.026, PMID: 21924933
30. Hon GC, Song CX, Du T, Jin F, Selvaraj S, Lee AY, Yen CA, Ye Z, Mao SQ, Wang BA, Kuan S, Edsall LE, Zhao BS, Xu GL, He C, Ren B, Yen Chia-an. 2014. 5mC oxidation by Tet2 modulates enhancer activity and timing of transcriptome reprogramming during differentiation. Molecular Cell 56: 286-297. doi: 10.1016/j.molcel.2014.08.026, PMID: 25263596
31. Huang Y, Pastor WA, Shen Y, Tahiliani M, Liu DR, Rao A. 2010. The behaviour of 5-hydroxymethylcytosine in bisulfite sequencing. PLoS One 5: e8888. doi: 10.1371/journal.pone.0008888, PMID: 20126651
32. Huang Y, Pastor WA, Zepeda-Martínez JA, Rao A. 2012. The anti-CMS technique for genome-wide mapping of 5-hydroxymethylcytosine. Nature Protocols 7: 1897-1908. doi: 10.1038/nprot.2012.103, PMID: 23018193
33. Huang Y, Rao A. 2014. Connections between TET proteins and aberrant DNA modification in cancer. Trends in Genetics 30: 464-474. doi: 10.1016/j.tig.2014.07.005, PMID: 25132561
34. Inlay M, Alt FW, Baltimore D, Xu Y. 2002. Essential roles of the kappa light chain intronic enhancer and 3' enhancer in kappa rearrangement and demethylation. Nature Immunology 3: 463-468. doi: 10.1038/ni790, PMID: 11967540
35. Ito S, Shen L, Dai Q, Wu SC, Collins LB, Swenberg JA, He C, Zhang Y. 2011. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333: 1300-1303. doi: 10.1126/science.1210597, PMID: 21778364
36. Kang J, Lienhard M, Pastor WA, Chawla A, Novotny M, Tsagaratou A, Lasken RS, Thompson EC, Surani MA, Koralov SB, Kalantry S, Chavez L, Rao A. 2015. Simultaneous deletion of the methylcytosine oxidases Tet1 and Tet3 increases transcriptome variability in early embryogenesis. PNAS 112: E4236-E4245. doi: 10.1073/pnas.1510510112
37. Klose RJ, Bird AP. 2006. Genomic DNA methylation: the mark and its mediators. Trends in Biochemical Sciences 31: 89-97. doi: 10.1016/j.tibs.2005.12.008, PMID: 16403636
38. Klug CA, Gerety SJ, Shah PC, Chen YY, Rice NR, Rosenberg N, Singh H. 1994. The v-abl tyrosine kinase negatively regulates NF-kappa B/Rel factors and blocks kappa gene transcription in pre-B lymphocytes. Genes & Development 8: 678-687. doi: 10.1101/gad.8.6.678, PMID: 7926758
39. Ko M, An J, Bandukwala HS, Chavez L, AijöT, Pastor WA, Segal MF, Li H, Koh KP, Lähdesmä ki H, Hogan PG, Aravind L, Rao A, ÄijöT, Rao A. 2013. Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX. Nature 497: 122-126. doi: 10.1038/nature12052, PMID: 23563267
40. Ko M, An J, Pastor WA, Koralov SB, Rajewsky K, Rao A. 2015. TET proteins and 5-methylcytosine oxidation in hematological cancers. Immunological Reviews 263: 6-21. doi: 10.1111/imr.12239, PMID: 25510268
41. Ko M, Bandukwala HS, An J, Lamperti ED, Thompson EC, Hastie R, Tsangaratou A, Rajewsky K, Koralov SB, Rao A. 2011. Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice. PNAS 108: 14566-14571. doi: 10.1073/pnas.1112317108
42. Ko M, Huang Y, Jankowska AM, Pape UJ, Tahiliani M, Bandukwala HS, An J, Lamperti ED, Koh KP, Ganetzky R, Liu XS, Aravind L, Agarwal S, Maciejewski JP, Rao A. 2010. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 468: 839-843. doi: 10.1038/nature09586, PMID: 21057493
43. Koh KP, Yabuuchi A, Rao S, Huang Y, Cunniff K, Nardone J, Laiho A, Tahiliani M, Sommer CA, Mostoslavsky G, Lahesmaa R, Orkin SH, Rodig SJ, Daley GQ, Rao A. 2011. Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell 8: 200-213. doi: 10.1016/j.stem.2011.01.008, PMID: 21295276
44. Kraus M, Alimzhanov MB, Rajewsky N, Rajewsky K. 2004. Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha/beta heterodimer. Cell 117: 787-800. doi: 10.1016/j.cell.2004.05.014, PMID: 15186779
45. Kulis M, Merkel A, Heath S, Queirós AC, Schuyler RP, Castellano G, Beekman R, Raineri E, Esteve A, Clot G, Verdaguer-Dot N, Duran-Ferrer M, Russiñol N, Vilarrasa-Blasi R, Ecker S, Pancaldi V, Rico D, Agueda L, Blanc J, Richardson D, et al. 2015. Whole-genome fingerprint of the DNA methylome during human B cell differentiation. Nature Genetics 47: 746-756. doi: 10.1038/ng.3291, PMID: 26053498
46. Langmead B, Salzberg SL. 2012. Fast gapped-read alignment with Bowtie 2. Nature Methods 9: 357-359. doi: 10.1038/nmeth.1923, PMID: 22388286
47. Levin-Klein R, Bergman Y. 2014. Epigenetic regulation of monoallelic rearrangement (allelic exclusion) of antigen receptor genes. Frontiers in Immunology 5: 625. doi: 10.3389/fimmu.2014.00625, PMID: 25538709
48. Lienhard M, Grimm C, Morkel M, Herwig R, Chavez L. 2014. Medips: genome-wide differential coverage analysis of sequencing data derived from DNA enrichment experiments. Bioinformatics 30: 284-286. doi: 10.1093/bioinformatics/btt650, PMID: 24227674
49. Lin H, Grosschedl R. 1995. Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature 376: 263-267. doi: 10.1038/376263a0, PMID: 7542362
50. Lin X, Sun D, Rodriguez B, Zhao Q, Sun H, Zhang Y, Li W. 2013. BSeQC: quality control of bisulfite sequencing experiments. Bioinformatics 29: 3227-3229. doi: 10.1093/bioinformatics/btt548, PMID: 24064417
51. Lin YC, Jhunjhunwala S, Benner C, Heinz S, Welinder E, Mansson R, Sigvardsson M, Hagman J, Espinoza CA, Dutkowski J, Ideker T, Glass CK, Murre C. 2010. A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate. Nature Immunology 11: 635-643. doi: 10.1038/ni.1891, PMID: 20543837
52. Lu R, Medina KL, Lancki DW, Singh H. 2003. IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development. Genes & Development 17: 1703-1708. doi: 10.1101/gad.1104803, PMID: 12832394
53. Ma S, Turetsky A, Trinh L, Lu R. 2006. IFN regulatory factor 4 and 8 promote Ig light chain kappa locus activation in pre-B cell development. The Journal of Immunology 177: 7898-7904. doi: 10.4049/jimmunol.177.11.7898, PMID: 17114461
54. Mandal M, Hamel KM, Maienschein-Cline M, Tanaka A, Teng G, Tuteja JH, Bunker JJ, Bahroos N, Eppig JJ, Schatz DG, Clark MR. 2015. Histone reader BRWD1 targets and restricts recombination to the Igk locus. Nature Immunology 16: 1094-1103. doi: 10.1038/ni.3249, PMID: 26301565
55. Manoharan A, Du Roure C, Rolink AG, Matthias P. 2015. De novo DNA Methyltransferases Dnmt3a and Dnmt3b regulate the onset of Igk light chain rearrangement during early B-cell development. European Journal of Immunology 45: 2343-2355. doi: 10.1002/eji.201445035, PMID: 26059604
56. Martinez GJ, Pereira RM, ÄijöT, Kim EY, Marangoni F, Pipkin ME, Togher S, Heissmeyer V, Zhang YC, Crotty S, Lamperti ED, Ansel KM, Mempel TR, Lähdesmäki H, Hogan PG, Rao A. 2015. The transcription factor NFAT promotes exhaustion of activated CD8+ T cells. Immunity 42: 265-278. doi: 10.1016/j.immuni.2015.01.006, PMID: 25680272
57. Mellén M, Ayata P, Dewell S, Kriaucionis S, Heintz N. 2012. MeCP2 Binds to 5hmC Enriched within Active Genes and Accessible Chromatin in the Nervous System. Cell 151: 1417-1430. doi: 10.1016/j.cell.2012.11.022
58. Muljo SA, Schlissel MS. 2003. A small molecule Abl kinase inhibitor induces differentiation of Abelson virus-transformed pre-B cell lines. Nature Immunology 4: 31-37. doi: 10.1038/ni870
59. Murre C. 2005. Helix-loop-helix proteins and lymphocyte development. Nature Immunology 6: 1079-1086. doi: 10.1038/ni1260
60. Ooi SK, O’Donnell AH, Bestor TH. 2009. Mammalian cytosine methylation at a glance. Journal of Cell Science 122: 2787-2791. doi: 10.1242/jcs.015123, PMID: 19657014
61. Pastor WA, Aravind L, Rao A. 2013. TETonic shift: biological roles of TET proteins in DNA demethylation and transcription. Nature Reviews Molecular Cell Biology 14: 341-356. doi: 10.1038/nrm3589, PMID: 23698584
62. Pastor WA, Huang Y, Henderson HR, Agarwal S, Rao A. 2012. The glib technique for genome-wide mapping of 5-hydroxymethylcytosine. Nature Protocols 7: 1909-1917. doi: 10.1038/nprot.2012.104, PMID: 23018194
63. Pastor WA, Pape UJ, Huang Y, Henderson HR, Lister R, Ko M, McLoughlin EM, Brudno Y, Mahapatra S, Kapranov P, Tahiliani M, Daley GQ, Liu XS, Ecker JR, Milos PM, Agarwal S, Rao A. 2011. Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells. Nature 473: 394-397. doi: 10.1038/nature10102, PMID: 21552279
64. Ramírez F, Ryan DP, Grüning B, Bhardwaj V, Kilpert F, Richter AS, Heyne S, Dündar F, Manke T. 2016. deepTools2: a next generation web server for deep-sequencing data analysis. Nucleic Acids Research 44: W160-W165. doi: 10.1093/nar/gkw257
65. Schübeler D. 2015. Function and information content of DNA methylation. Nature 517: 321-326. doi: 10.1038/nature14192
66. Shen L, Wu H, Diep D, Yamaguchi S, D’Alessio AC, Fung HL, Zhang K, Zhang Y. 2013. Genome-wide analysis reveals TET-and TDG-dependent 5-methylcytosine oxidation dynamics. Cell 153: 692-706. doi: 10.1016/j.cell.2013.04.002, PMID: 23602152
67. Shlyueva D, Stampfel G, Stark A. 2014. Transcriptional enhancers: from properties to genome-wide predictions. Nature Reviews Genetics 15: 272-286. doi: 10.1038/nrg3682
68. Song CX, Szulwach KE, Dai Q, Fu Y, Mao SQ, Lin L, Street C, Li Y, Poidevin M, Wu H, Gao J, Liu P, Li L, Xu GL, Jin P, He C. 2013a. Genome-wide profiling of 5-formylcytosine reveals its roles in epigenetic priming. Cell 153: 678-691. doi: 10.1016/j.cell.2013.04.001, PMID: 23602153
69. Song L, Zhang Z, Grasfeder LL, Boyle AP, Giresi PG, Lee BK, Sheffield NC, Gräf S, Huss M, Keefe D, Liu Z, London D, McDaniell RM, Shibata Y, Showers KA, Simon JM, Vales T, Wang T, Winter D, Zhang Z, et al. 2011. Open chromatin defined by DNaseI and FAIRE identifies regulatory elements that shape cell-type identity. Genome Research 21: 1757-1767. doi: 10.1101/gr.121541.111, PMID: 21750106
70. Song Q, Decato B, Hong EE, Zhou M, Fang F, Qu J, Garvin T, Kessler M, Zhou J, Smith AD. 2013b. A Reference Methylome Database and Analysis Pipeline to Facilitate Integrative and Comparative Epigenomics. PLoS One 8: e81148. doi: 10.1371/journal.pone.0081148
71. Spruijt CG, Gnerlich F, Smits AH, Pfaffeneder T, Jansen PW, Bauer C, Münzel M, Wagner M, Müller M, Khan F, Eberl HC, Mensinga A, Brinkman AB, Lephikov K, Müller U, Walter J, Boelens R, van Ingen H, Leonhardt H, Carell T, et al. 2013. Dynamic readers for 5-(hydroxy)methylcytosine and its oxidized derivatives. Cell 152: 1146-1159. doi: 10.1016/j.cell.2013.02.004, PMID: 23434322
72. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, Agarwal S, Iyer LM, Liu DR, Aravind L, Rao A. 2009. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324: 930-935. doi: 10.1126/science.1170116, PMID: 19372391
73. Thurman RE, Rynes E, Humbert R, Vierstra J, Maurano MT, Haugen E, Sheffield NC, Stergachis AB, Wang H, Vernot B, Garg K, John S, Sandstrom R, Bates D, Boatman L, Canfield TK, Diegel M, Dunn D, Ebersol AK, Frum T, et al. 2012. The accessible chromatin landscape of the human genome. Nature 489: 75-82. doi: 10.1038/nature11232, PMID: 22955617
74. Tsagaratou A, González-Avalos E, Rautio S, Scott-Browne JP, Togher S, Pastor WA, Rothenberg EV, Chavez L, Lähdesmäki H, Rao A. 2016. TET proteins regulate the lineage specification and TCR-mediated expansion of iNKT cells. Nature Immunology. In press. doi: 10.1038/ni.3630, PMID: 27869820
75. Victora GD, Nussenzweig MC. 2012. Germinal centers. Annual Review of Immunology 30: 429-457. doi: 10.1146/annurev-immunol-020711-075032, PMID: 22224772
76. Vieira P, Cumano A. 2004. Differentiation of B lymphocytes from hematopoietic stem cells. Methods in Molecular Biology 271: 67-76. doi: 10.1385/1-59259-796-3: 067, PMID: 15146113
77. Wang Y, Xiao M, Chen X, Chen L, Xu Y, Lv L, Wang P, Yang H, Ma S, Lin H, Jiao B, Ren R, Ye D, Guan KL, Xiong Y. 2015. WT1 recruits TET2 to regulate its target gene expression and suppress leukemia cell proliferation. Molecular Cell 57: 662-673. doi: 10.1016/j.molcel.2014.12.023, PMID: 25601757
78. Wu H, Zhang Y. 2014. Reversing DNA methylation: mechanisms, genomics, and biological functions. Cell 156: 45-68. doi: 10.1016/j.cell.2013.12.019, PMID: 24439369
79. Xi Y, Li W. 2009. Bsmap: whole genome bisulfite sequence MAPping program. BMC Bioinformatics 10: 232. doi: 10.1186/1471-2105-10-232
80. Yancopoulos G, Alt FW. 1985. Developmentally controlled and tissue-specific expression of unrearranged VH gene segments. Cell 40: 271-281. doi: 10.1016/0092-8674(85)90141-2
81. Zhou X, Xiang Y, Garrard WT. 2010. The Igk gene enhancers, E3' and Ed, are essential for triggering transcription. The Journal of Immunology 185: 7544-7552. doi: 10.4049/jimmunol.1002665, PMID: 21076060
82. Ziller MJ, Gu H, Müller F, Donaghey J, Tsai LT, Kohlbacher O, De Jager PL, Rosen ED, Bennett DA, Bernstein BE, Gnirke A, Meissner A. 2013. Charting a dynamic DNA methylation landscape of the human genome. Nature 500: 477-481. doi: 10.1038/nature12433, PMID: 23925113